& Mieti-Turk, D
(1991) Glutathione deficiency produced by inhibition of its synthesis and its reversal
Fate Therapeutics has dosed 13 participants in their phase I basket trial of their CAR-T cells, which are derived from induced pluripotent stem cells (iPSCs)
Landscapes Health & Medical Sciences (AREA) Chemical & Material Sciences (AREA) Organic Chemistry (AREA) Life Sciences & Earth Sciences (AREA) General Health & Medical Sciences (AREA) Medicinal Chemistry (AREA) Bioinformatics & Cheminformatics (AREA) Engineering & Computer Science (AREA) Veterinary Medicine (AREA) Animal Behavior & Ethology (AREA) Public Health (AREA) Pharmacology & Pharmacy (AREA) Chemical Kinetics & Catalysis (AREA) General Chemical & Material Sciences (AREA) Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA) Neurology (AREA) Biomedical Technology (AREA) Neurosurgery (AREA) Proteomics, Peptides & Aminoacids (AREA) Biochemistry (AREA) Molecular Biology (AREA) Genetics & Genomics (AREA) Biophysics (AREA) Crystallography & Structural Chemistry (AREA) Orthopedic Medicine & Surgery (AREA) Psychiatry (AREA) Psychology (AREA) Ophthalmology & Optometry (AREA) Physical Education & Sports Medicine (AREA) Hospice & Palliative Care (AREA) Dermatology (AREA) Epidemiology (AREA) Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA) Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA) Peptides Or Proteins (AREA) Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA) Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA) Abstract The present technology relates to compounds, kits, compositions, and methods useful for the treatment of numerous pathologies including dementia, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, defective wound healing, and/or sensorineural hearing and vision loss
PMID: 149 AytonSMoreauCDevosDBushAI
